Sean Bohen

Insider Reports History

Entity
Individual
Location
C/O Olema Pharmaceuticals, Inc., 512 2 Nd Street, 4 Th Floor, San Francisco, CA
Signature
/s/ Shane Kovacs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean Bohen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. PRESIDENT AND CEO, Director Common Stock 145K $1.02M $7.02 Nov 22, 2023 Direct
Olema Pharmaceuticals, Inc. PRESIDENT AND CEO, Director Stock Option (Right to Buy) 622K Feb 1, 2024 Direct

Insider Reports Filed by Sean Bohen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OLMA Olema Pharmaceuticals, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 PRESIDENT AND CEO, Director
OLMA Olema Pharmaceuticals, Inc. Nov 20, 2023 4 -$824K 4 Nov 22, 2023 PRESIDENT AND CEO, Director
OLMA Olema Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 President and CEO, Director
OLMA Olema Pharmaceuticals, Inc. Sep 21, 2022 1 $0 4/A Sep 23, 2022 PRESIDENT AND CEO, Director
OLMA Olema Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 PRESIDENT AND CEO, Director
OLMA Olema Pharmaceuticals, Inc. Oct 14, 2021 4 -$128K 4 Oct 15, 2021 PRESIDENT AND CEO, Director
OLMA Olema Pharmaceuticals, Inc. Sep 27, 2021 3 -$27.4K 4 Sep 29, 2021 PRESIDENT AND CEO, Director
OLMA Olema Pharmaceuticals, Inc. Sep 7, 2021 6 -$76.7K 4 Sep 9, 2021 PRESIDENT AND CEO, Director
OLMA Olema Pharmaceuticals, Inc. Sep 1, 2021 3 -$22K 4 Sep 3, 2021 PRESIDENT AND CEO, Director